1
/
of
1
Elabscience
SKU:PKSH031464
Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag)
Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag)
Regular price
$855.00 USD
Regular price
Sale price
$855.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag), a cutting-edge product meticulously engineered to cater to the demanding needs of the scientific community. This protein, derived from human sources, encompasses amino acids 672 to 710, and is fused with both a Histidine (His) and Glutathione S-transferase (GST) tag for enhanced stability and ease of purification.
Crafted with utmost precision, this recombinant protein offers an invaluable tool for researchers and scientists engaged in the study of Alzheimer's disease and related neurodegenerative disorders. Its strategic selection of amino acids ensures the inclusion of the crucial Beta-amyloid 39/Beta-APP39 region, enabling comprehensive investigations into the underlying mechanisms and pathological implications associated with this specific segment.
The incorporation of the His and GST tags further amplifies the utility of this protein. The His tag facilitates efficient purification through affinity chromatography, streamlining the experimental workflow and saving valuable time. Meanwhile, the GST tag enhances the stability of the protein, safeguarding its structural integrity during storage and experimental manipulations.
This Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag) is produced using state-of-the-art recombinant DNA technology, ensuring high purity and batch-to-batch consistency. Rigorous quality control measures are implemented throughout the manufacturing process to guarantee the utmost reliability and reproducibility of results.
With its exceptional quality and versatility, this protein serves as an indispensable asset for a wide range of applications, including but not limited to protein-protein interaction studies, drug screening assays, and structural biology investigations. Its availability in a ready-to-use format expedites experimental setups, empowering researchers to delve deeper into the intricate complexities of Beta-amyloid 39/Beta-APP39 biology.
In summary, the Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag) stands as a pinnacle of scientific innovation, offering an unparalleled tool for elucidating the mysteries surrounding Alzheimer's disease and related neurodegenerative disorders. Its exceptional purity, stability, and ease of use make it an indispensable resource for researchers striving to unravel the intricate mechanisms underlying these debilitating conditions.
Crafted with utmost precision, this recombinant protein offers an invaluable tool for researchers and scientists engaged in the study of Alzheimer's disease and related neurodegenerative disorders. Its strategic selection of amino acids ensures the inclusion of the crucial Beta-amyloid 39/Beta-APP39 region, enabling comprehensive investigations into the underlying mechanisms and pathological implications associated with this specific segment.
The incorporation of the His and GST tags further amplifies the utility of this protein. The His tag facilitates efficient purification through affinity chromatography, streamlining the experimental workflow and saving valuable time. Meanwhile, the GST tag enhances the stability of the protein, safeguarding its structural integrity during storage and experimental manipulations.
This Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag) is produced using state-of-the-art recombinant DNA technology, ensuring high purity and batch-to-batch consistency. Rigorous quality control measures are implemented throughout the manufacturing process to guarantee the utmost reliability and reproducibility of results.
With its exceptional quality and versatility, this protein serves as an indispensable asset for a wide range of applications, including but not limited to protein-protein interaction studies, drug screening assays, and structural biology investigations. Its availability in a ready-to-use format expedites experimental setups, empowering researchers to delve deeper into the intricate complexities of Beta-amyloid 39/Beta-APP39 biology.
In summary, the Recombinant Human Beta-amyloid 39/Beta-APP39 Protein (aa 672-710, His & GST Tag) stands as a pinnacle of scientific innovation, offering an unparalleled tool for elucidating the mysteries surrounding Alzheimer's disease and related neurodegenerative disorders. Its exceptional purity, stability, and ease of use make it an indispensable resource for researchers striving to unravel the intricate mechanisms underlying these debilitating conditions.
Share
